Chemicals - Green Petrochemicals & Specialty Chemicals
Strategic Profile
The company offers bio mono ethylene, di ethylene, and tri ethylene glycols; ethyl/butyl glycol ethers and acetates, brake fluids; bio-polymers; biofuels; specialty chemicals; molasses and grain based extra neutral alcohol; and specialty gases. Its products find applications across pharma and healthcare, textiles, automotive, personal care, industrial and manufacturing, paints and coatings, oil and gas, food ingredients, and packaging industries.
Cyborg Score Rationale
India Glycols demonstrates solid fundamentals with strong recent revenue and earnings growth. However, the company has delivered poor sales growth of 6.62% over the past five years and has a low return on equity of 8.82% over the last 3 years, indicating execution challenges despite recent momentum.
Top Insights
Strong 2024 performance with 14.4% revenue growth to 37.68 billion and 33.5% earnings growth to 2.31 billion
Received US FDA Establishment Inspection Report with no observations; successfully commissioned additional 200 KLPD grain-based capacity
NCLT rescheduled shareholders and unsecured creditors meetings to March 24, 2026
Portfolio diversification across chemicals, specialty products, potable spirits, and nutraceuticals reduces revenue concentration risk
Named Competitors
Monoethylene Glycol & Specialty Chemicals — Global chemical leader with diversified product portfolio
Polyols & Specialty Chemicals — Major petrochemical and chemical manufacturer
Specialty Chemicals — Leading Indian diversified conglomerate with chemical operations
Recent Developments
(March 2026) NCLT rescheduled shareholder meetings from March 9 to March 24, 2026